AR and cancer: In fact, NCOA2 is able to reprogramme AR signalling in cancer cells towards metabolism for survival from therapy (Dasgupta et al. 2015), while NCOA3 drives proliferation and promotes survival pathways to combat the activation of apoptosis (Hirase et al. 2000).